An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
May 19th, 2020
6.7K views
A rodent model of left heart volume overload from mitral regurgitation is reported. Mitral regurgitation of controlled severity is induced by advancing a needle of defined dimensions into the anterior leaflet of the mitral valve, in a beating heart, with ultrasound guidance.
Overview
This article presents a rodent model of left heart volume overload due to mitral regurgitation, induced in a beating heart using ultrasound guidance. The model aims to enhance understanding of heart failure mechanisms.
Key Study Components
Area of Science
- Cardiovascular physiology
- Heart failure research
- Rodent models
Background
- Mitral regurgitation is a prevalent valve disease.
- It can lead to significant heart failure.
- This model mimics the hemodynamics of patients with mitral regurgitation.
- Understanding this condition is crucial for developing treatments.
Purpose of Study
- To create a clinically relevant model of mitral regurgitation.
- To investigate the underlying mechanisms of heart failure.
- To facilitate future research in cardiovascular diseases.
Methods Used
- Induction of mitral regurgitation using a needle technique.
- Ultrasound guidance for precise needle placement.
- Left thoracotomy performed on adult Sprague-Dawley rats.
- Use of a 6-0 PROLENE suture for pursestring suturing.
Main Results
- The model successfully mimics the hemodynamics of mitral regurgitation.
- Visual demonstration aids in understanding the procedure.
- Experience in microsurgery enhances protocol replication.
- Familiarity with echocardiographic imaging is essential.
Conclusions
- This model is valuable for studying heart failure mechanisms.
- It provides insights into the clinical relevance of mitral regurgitation.
- Future studies can build on this model to explore therapeutic options.
Frequently Asked Questions
What is mitral regurgitation?
Mitral regurgitation is a valve disease where blood leaks backward into the heart, potentially leading to heart failure.
How is the model induced?
The model is induced by advancing a needle into the mitral valve under ultrasound guidance.
What are the key skills required for this procedure?
Skills in microsurgery and echocardiographic imaging are crucial for successful implementation.
Why is this model clinically relevant?
It mimics the hemodynamics observed in patients, providing insights into heart failure mechanisms.
What animal model is used in this study?
The study uses adult Sprague-Dawley rats for the model.
What is the significance of this research?
It enhances understanding of mitral regurgitation and its impact on heart failure, aiding future therapeutic developments.
Executive Industry Relevance
This model enables mechanistic investigation of mitral regurgitation-induced cardiac remodeling, supporting target validation in heart failure pathways. By replicating clinically relevant hemodynamics in a rodent system, it provides a disease-relevant platform for preclinical de-risking of therapeutic candidates. The model facilitates longitudinal assessment of structural and functional changes, informing go/no-go decisions in early discovery pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses related to volume overload signaling pathways.
- Operational Value: Provides reproducible induction of severe mitral regurgitation for consistent phenotype generation.
- Predictive Value: Supports assessment of target engagement through quantifiable cardiac remodeling endpoints.
Screening & Assay Development
- Assay Readiness: Generates validated biological systems with confirmed MR severity via echocardiography for downstream compound testing.
- Quantitative Outputs: Delivers measurable parameters including MR jet area fraction, velocity time integral, and pulmonary vein flow ratios.
- Scalability Consideration: Requires expertise in microsurgery and imaging, limiting high-throughput application but supporting focused mechanistic screening.
Translational & Preclinical Research
- Disease Relevance: Mimics low-pressure volume overload hemodynamics observed in human mitral regurgitation.
- Translational Continuity: Allows study of early versus late onset MR impact on ventricular remodeling, informing therapeutic timing.
- Risk-Adjusted Advancement: Enables evaluation of candidate compounds on reversal of spherical dilation and pulmonary flow reversal biomarkers.
Pipeline & Workflow Integration
Positions as a discovery biology tool for hypothesis testing in heart failure mechanisms, enabling progression from target identification to preclinical validation through quantifiable hemodynamic and structural phenotyping.
- Discovery Biology: Supports pathway clarification and biological de-risking of targets involved in cardiac stress response.
- Analytics: Provides quantitative echocardiographic readouts (MR jet area, VTI, systolic/diastolic ratio) for comparative condition analysis.
- Translational Research: Connects to preclinical validation by modeling progressive ventricular dilation and pulmonary hypertension signs.
- Enterprise Reuse: Establishes a reusable surgical-imaging platform for volume overload model generation across cardiology discovery programs.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in MR pathogenesis through controlled, image-guided lesion generation.
- Operational Value: Standardizes MR induction via pursestring suture technique and real-time ultrasound guidance.
- Strategic Value: Improves go/no-go decisions by linking target modulation to reversal of severe remodeling phenotypes.
- Portfolio Impact: Enables risk-adjusted prioritization based on efficacy in normalizing atrial area fraction and pulmonary vein flow dynamics.
Implementation Considerations
- Requires microsurgical expertise for thoracotomy, pursestring suturing, and needle manipulation.
- Dependent on echocardiography infrastructure and operator proficiency in color and Doppler imaging.
- Necessitates postoperative management including analgesia administration and vital sign monitoring.
- Limited by rat size constraints for longitudinal imaging and device compatibility.
- Involves technical complexity in achieving consistent leaflet puncture without ventricular damage.
Biopharma FAQs
Why does MR jet area fraction matter for target validation?
MR jet area fraction quantifies regurgitant severity, with values around 42% indicating severe volume overload. This metric enables objective assessment of therapeutic impact on reducing pathological backflow, supporting go/no-go decisions based on hemodynamic improvement.
How does independent variable isolation fit the discovery pipeline?
Isolating mitral leaflet puncture as the independent variable ensures observed remodeling stems from volume overload rather than surgical confounders. This specificity strengthens causal inference in target validation studies by linking phenotypic changes directly to MR induction.
What quantitative dependent variable measurements enable mechanistic de-risking?
Dependent variables include left atrial area, MR jet velocity time integral (~40 cm), and pulmonary vein systolic/diastolic ratio shift from 0.9 to -0.7. These quantifiable outputs allow measurement of remodeling progression and therapeutic effect on reverse structural and functional derangements.
Why do replication requirements matter for cross-functional collaboration?
Reproducibility of severe MR induction ensures consistent phenotypes across laboratories, enabling reliable data sharing between discovery, toxicology, and translational teams. Standardized outcomes reduce variability in target validation studies and support multi-site preclinical programs.
What statistical analysis capabilities are required before implementation?
Implementation requires capability to analyze continuous wave Doppler waveforms for velocity time integral calculation and planimetry for MR jet area quantification. Statistical comparison of pre- and post-intervention echocardiographic parameters is essential to determine significant changes in remodeling endpoints.
